New and emerging therapies for diabetic kidney disease

被引：0

作者：

Ricardo Correa-Rotter

Louise J. Maple-Brown

Rakesh Sahay

Katherine R. Tuttle

Ifeoma I. Ulasi

机构：

[1] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,Menzies School of Health Research

[2] Universidad Nacional Autónoma de México,Department of Endocrinology

[3] Charles Darwin University,Providence Medical Research Center

[4] Royal Darwin and Palmerston Hospitals,Kidney Research Institute and Institute of Translational Health Sciences

[5] NT Health,Department of Medicine, College of Medicine

[6] Osmania Medical College,Renal Unit, Department of Medicine

[7] Providence Inland Northwest Health,Renal Unit, Department of Internal Medicine

[8] University of Washington,undefined

[9] University of Nigeria,undefined

[10] Ituku-Ozalla,undefined

[11] University of Nigeria Teaching Hospital,undefined

[12] Ituku-Ozalla,undefined

[13] Alex Ekwueme Federal University Teaching Hospital,undefined

来源：

Nature Reviews Nephrology | 2024年 / 20卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The theme of World Kidney Day 2024 is “kidney health for all — advancing equitable access to care and optimal medication practice”. To mark this event, Nature Reviews Nephrology invited five researchers from different geographical regions worldwide to discuss the impact of new and emerging therapies for diabetic kidney disease on patient care as well as the barriers that must be overcome to ensure equitable access to these therapies.

引用

页码：156 / 160

页数：4

共 50 条

[31] Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies
Del Vecchio, Lucia
Locatelli, Francesco
EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (04) : 495 - 506
[32] The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease
Chaudhary, Kunal
Phadke, Gautam
Nistala, Ravi
Weidmeyer, Charles E.
McFarlane, Samy I.
Whaley-Connell, Adam
CURRENT DIABETES REPORTS, 2010, 10 (01) : 37 - 42
[33] Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
Pak, Eun Seon
Cha, Jin Joo
Cha, Dae Ryong
Kanasaki, Keizo
Ha, Hunjoo
KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 : S74 - S88
[34] The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease
Kunal Chaudhary
Gautam Phadke
Ravi Nistala
Charles E. Weidmeyer
Samy I. McFarlane
Adam Whaley-Connell
Current Diabetes Reports, 2010, 10 : 37 - 42
[35] Mirogabalin and emerging therapies for diabetic neuropathy
Javed, Saad
Alam, Uazman
Malik, Rayaz A.
JOURNAL OF PAIN RESEARCH, 2018, 11 : 1559 - 1566
[36] DIABETIC KIDNEY DISEASE VE-PTP phosphatase: a new target for diabetic kidney disease
Allison, Susan J.
NATURE REVIEWS NEPHROLOGY, 2019, 15 (06) : 317 - 317
[37] Emerging therapies for diabetic macular edema
Schwartz, Stephen G.
Flynn, Harry W., Jr.
Scott, Ingrid U.
EXPERT REVIEW OF OPHTHALMOLOGY, 2009, 4 (02) : 163 - 171
[38] Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease
Tuttle, Katherine R.
Wong, Leslie
St Peter, Wendy
Roberts, Glenda
Rangaswami, Janani
Mottl, Amy
Kliger, Alan S.
Harris, Raymond C.
Gee, Patrick O.
Fowler, Kevin
Cherney, David
Brosius, Frank C., III
Argyropoulos, Christos
Quaggin, Susan E.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (07): : 1092 - 1103
[39] Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
Valdivielso, Jose M.
Balafa, Olga
Ekart, Robert
Ferro, Charles J.
Mallamaci, Francesca
Mark, Patrick B.
Rossignol, Patrick
Sarafidis, Pantelis
del Vecchio, Lucia
Ortiz, Alberto
DRUGS, 2021, 81 (13) : 1467 - 1489
[40] Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
José M. Valdivielso
Olga Balafa
Robert Ekart
Charles J. Ferro
Francesca Mallamaci
Patrick B. Mark
Patrick Rossignol
Pantelis Sarafidis
Lucia Del Vecchio
Alberto Ortiz
Drugs, 2021, 81 : 1467 - 1489

← 1 2 3 4 5 →